Faeth Therapeutics Inc stock is traded at $10.03, with a volume of 1,040,241. It is down -5.82% in the last 24 hours and down -53.37% over the past month. Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Previous Close:
$10.65
Open:
$10.51
24h Volume:
1,040,241
Relative Volume:
1.03
Market Cap:
$259.21M
Revenue:
-
Net Income/Loss:
-$184.46M
P/E Ratio:
-
EPS:
-$142.73
Net Cash Flow:
-$24.11M
1W Performance:
-54.51%
1M Performance:
-53.37%
6M Performance:
0.00%
1Y Performance:
0.00%
1-Day Range:
$9.67$10.63
1-Week Range:
$9.67$16.64
52-Week Range:
$9.67$42.14
Faeth Therapeutics Inc Stock (FTH) Company Profile
Name
Faeth Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(240) 243-8000Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS